CVS Health Corp vs Vanguard Intermediate Term Corporate Bond ETF — how do they compare? CVS Health Corp trades at $93.62 (market cap $119.58B), while Vanguard Intermediate Term Corporate Bond ETF trades at $81.18. The key difference: CVS Health Corp pays a 2.84% dividend while Vanguard Intermediate Term Corporate Bond ETF pays none, and CVS Health Corp is trading nearer its 52-week high, Vanguard Intermediate Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| CVS | VCIT | |
|---|---|---|
Market Cap | $119.58B | — |
Sector | Health | Fixed Income |
52-Week High | $110.60 | $84.82 |
52-Week Low | $65.51 | $81.07 |
Enterprise Value | $181.93B | — |
Dividend Yield | 2.84% | — |
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.
Read more on VCIT →